drugset / Trial / NCT07166263
Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study will evaluate the safety and efficacy of NK510 in the treatment of relapsed and refractory advanced gastric cancer and colorectal cancer.NK510 will be administered by intravenous infusion for systemic therapy and intraperitoneal perfusion therapy. The safety and efficacy of this treatment will be evaluated.
Timeline
- Start
- 2025-11
- Primary completion
- 2027-06
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NK510 | Cell therapy | — | Intravenous |